2 edition of Bioassay of 6-nitrobenzimidazole for possible carcinogenicity. found in the catalog.
Bioassay of 6-nitrobenzimidazole for possible carcinogenicity.
National Cancer Institute (U.S.). Division of Cancer Cause and Prevention.
1979 by Dept. of Health, Education, and Welfare, Public Health Service, National Institutes of Health, National Cancer Institute, Division of Cancer Cause and Prevention, Carcinogenesis Testing Program in Bethesda, Md .
Written in English
|Series||DHEW publication -- no. (NIH) 79-1372, Carcinogenesis technical report series -- no. 117|
|The Physical Object|
|Pagination||114 p. in various pagings :|
|Number of Pages||114|
Aquatic species at risk
step to man
A Return on Investment Model for Air Force Technology Transfer
A house in the country
The Lost Heiress of Hawkscliff
IVe Got Imagination (Rachels Fun Time Series, 3)
SOFTBANK INVESTMENT INTL (STRATEGIC) LTD
Speech of the Earl of Donoughmore in the House of Lords
Exam Set C 1977
Confessions and criticisms
By the United States in Congress assembled, April 21st, 1787
Insect and mite pests of tea in Ceylon and their control
Excavating the revolt of 1857
Ping vs Pong
play is not so ydle a thing
Get this from a library. Bioassay of 6-nitrobenzimidazole for possible carcinogenicity. [National Cancer Institute (U.S.). Division of Cancer Cause and Prevention.].
Bioassay of 6-nitrobenzimidazole for possible carcinogenicity (OCoLC) Material Type: Document, Government publication, National government publication, Internet resource: Document Type: Internet Resource, Computer File: All Authors / Contributors: National Cancer Institute (U.S.).
Division of Cancer Cause and Prevention. OCLC Number. This banner text can have markup. web; books; video; audio; software; images; Toggle navigation. Add to Book Bag Remove from Book Bag. Saved in: Bioassay of 6-nitrobenzimidazole for possible carcinogenicity.
Bibliographic Details; Corporate Author: National Cancer Institute (U.S.). Division of Cancer Cause and Prevention. Bioassay of malaoxon for possible carcinogenicity Published: (). Add to Book Bag Remove from Book Bag.
Saved in: Bioassay of 6-nitrobenzimidazole for possible carcinogenicity. Bibliographic Details; Corporate Author: National Cancer Institute (U.S.). Division of Cancer Cause and Prevention. a Bioassay of 6-nitrobenzimidazole for possible carcinogenicity |h [electronic resource].
Dunkel, V., Zeiger, E., Brusick, D., McCoy, E., McGregor, D., Mortelmans, K., Rosenkranz, H., and Simmon, V. () Reproducibility of microbial mutagenicity assays. A bioassay for possible carcinogenicity of 6-nitrobenzimidazole was conducted using Fische 34r 4 rats and B6C3F1 mice.
6-Nitrobenzi midazole was administere idn the feed, at. Author(s): Mason Research Institute.; National Institutes of Health (U.S.); Carcinogenesis Testing Program (U.S.) Title(s): Bioassay of 6-nitrobenzimidazole for.
REGULATORY TOXICOLOGY AND PHARMACOLOGY 3, () The Power and Interpretation of the Carcinogenicity Bioassay D. CLAYSON,I D. KREWSKI, AND 1. MUNRO Health Protection Branch, Health and Welfare Canada, Ottawa, Canada Received Carcinogenicity is a major consideration in the assessment of risks due to Cited by: Request PDF | Chemical carcinogenicity: Can it be predicted from knowledge of mutagenicity and allergic contact dermatitis.
| We investigated the suggestion [R.E. ELSEVIER Mutation Research () Genetic Toxicology QSARS of mutagens and carcinogens: Two case studies illustrating problems in the construction of models for noncongeneric chemicals 1 Romualdo Benigni a,*, Ann M. Richard b a Laborator3' of ComparatiL,e Toxicology and EcoToxicology, lstituto Superiore di SanitY, Viale Regina Elena Cited by: A series of novel 3-nitro-1H-1,2,4-triazole-based (and in some cases 2-nitro-1H-imidazole-based) amides and sulfonamides were characterized for their in vitro antitrypanosomal and antileishmanial.
EPA/ TR INVESTIGATION OF SELECTED POTENTIAL ENVIRONMENTAL CONTAMINANTS: NITROAROMATICS Philip H. Howard Joseph Santodonato Jitendra Saxena Judith Mailing Dorothy Greninger June Contract No. SRC No. L Project Officer - Frank Kover Prepared for Office of Toxic.  J.K.
Haseman, A.-M. Clark, Carcinogenicity results for laboratory animal studies used to assess the predictivity of four in vitro genetic toxicity assays for rodent carcinogenicity, Environ.
Link to the full study report - National Toxicology Program - National. COMPOUND Acrylic resins (acrylics) Acrylonitrile H2 C:CHCN Acrylonitrile - buta- diene - styrene (resins) (ABS resins) Alcohol (See: Ethyl Alcohol) Aldrin (See: 1,2,3,4, 10, Hexachloro-l, 4, 4a, 5 s 8, 8a-hexahy- dro-endo-exo-1, 8-dimethano-naphtha- lene) PRODUCT SIC.
CIC Meeting Transcript Octo - OEHHA - State of California. Phosphodiesterase 4 inhibitors. PubMed. Zebda, Rema; Paller, Amy S. Historically, drugs available for treating atopic dermatitis (AD) have been limited to topical cort.
A Structure-Activity Analysis of the Variation in Oxime Efficacy Against Nerve Agents. DTIC Science & Technology. Literature 3. DATES COVERED (From - .